Efficacy and safety of bevacizumab for vestibular schwannomas in neurofibromatosis type-2: a systematic review and meta-analysis. Khanmirzaei A, Safari Dehnavi N, Habibi MA, Delbari P, et al. Eur Arch Otorhinolaryngol 2026 Apr 21. doi: 10.1007/s00405-026-10174.

Read + Share

Amedeo Smart

Independent Medical Education

Khanmirzaei A, Safari Dehnavi N, Habibi MA, Delbari P, et al. Efficacy and safety of bevacizumab for vestibular schwannomas in neurofibromatosis type-2: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2026 Apr 21. doi: 10.1007/s00405-026-10174.
PMID: 42012512